Baloxavir is an anti-influenza agent extracted from patent WO 2017104691 A1.
References:
[1]. Shishido Takao, et al. Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug. WO 2017104691 A1.
















